{
  "tool": "tavily",
  "query": "abridge company last_disclosed_valuation_usd",
  "results": [
    {
      "title": "Healthcare startup Abridge tops $5 billion valuation in ...",
      "content": "Healthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation,",
      "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-300-million-led-by-vc-firm-andreessen-horowitz-2025-06-24/"
    },
    {
      "title": "Abridge $250M Series D Funding - $2.5B Valuation",
      "content": "Abridge: Series D Funding Round. Abridge has successfully raised $250M in Series D funding, reaching a valuation of $2.5B.",
      "url": "https://salestools.io/report/abridge-250m-series-d"
    },
    {
      "title": "Abridge scores $300M series E, boosting valuation to $5.3B",
      "content": "Expanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning",
      "url": "https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla"
    },
    {
      "title": "Medical AI startup Abridge closes $300M investment at ...",
      "content": "### Medical AI startup Abridge closes $300M investment at $5.3B valuation Medical software developer Abridge Inc. today disclosed that it has raised a $300 million funding round led by Andreessen Horowitz. To ease data management, healthcare organizations turn information from files such as medical notes into ICD-10 codes. Abridge can also generate medical billing codes, which serve a similar function as ICD-10 codes. \u201cEvery medical conversation is rich with the signals our healthcare system depends on,\u201d said Abridge co-founder and Chief Executive Officer Shiv Rao. Our new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.",
      "url": "https://siliconangle.com/2025/06/24/medical-ai-startup-abridge-closes-300m-investment-5-3b-valuation/"
    },
    {
      "title": "In just 4 months, AI medical scribe Abridge doubles ...",
      "content": "# In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entryand integration with Epic Systems, the dominant health record software. Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner Epic Systems. a16z, Abridge, AI, AI note-taking, Biotech & Health, In Brief, Startups",
      "url": "https://techcrunch.com/2025/06/24/in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b/"
    }
  ],
  "raw_content": "\nHealthcare startup Abridge tops $5 billion valuation in ...\nHealthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation,\n\nAbridge $250M Series D Funding - $2.5B Valuation\nAbridge: Series D Funding Round. Abridge has successfully raised $250M in Series D funding, reaching a valuation of $2.5B.\n\nAbridge scores $300M series E, boosting valuation to $5.3B\nExpanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning\n\nMedical AI startup Abridge closes $300M investment at ...\n### Medical AI startup Abridge closes $300M investment at $5.3B valuation Medical software developer Abridge Inc. today disclosed that it has raised a $300 million funding round led by Andreessen Horowitz. To ease data management, healthcare organizations turn information from files such as medical notes into ICD-10 codes. Abridge can also generate medical billing codes, which serve a similar function as ICD-10 codes. \u201cEvery medical conversation is rich with the signals our healthcare system depends on,\u201d said Abridge co-founder and Chief Executive Officer Shiv Rao. Our new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.\n\nIn just 4 months, AI medical scribe Abridge doubles ...\n# In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entryand integration with Epic Systems, the dominant health record software. Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner Epic Systems. a16z, Abridge, AI, AI note-taking, Biotech & Health, In Brief, Startups\n",
  "count": 5,
  "success": true
}